Nanoelectronics Meets Biomedicine imec and MIT Collaborate on Smart Diagnostics for Personalized Medicine

Related Vendors

FAULHABER Drive Systems

Taiwan Machine Tool & Accessory Builders' Association (TMBA)

Wuxi InfiMotion Technology Co., Ltd.

imec and MIT are combining their expertise in nanoelectronics, microsystems technology, and AI to accelerate the development of smart, minimally invasive diagnostic devices for personalized applications in hospitals, practices, and everyday life.

imec, the Belgian center for nanoelectronics and digital technologies, is collaborating with the Research Laboratory of Electronics at MIT to develop novel diagnostic platforms. The aim is to elevate personalized healthcare to a new level—from hospitals to everyday life.

Technology Alliance for the Medicine of the Future

The core of the collaboration is focused on minimally invasive, wearable devices that continuously monitor vital parameters and biomarkers. Based on advanced semiconductor technology and AI, these systems are designed to provide accurate health data and enable personalized therapies.The research combines the materials and microsystems expertise of MIT with imec's industrial transfer strength. This results in new sensor and actuator technologies at the nanoscale that offer high data density and quality despite low power consumption.

From Prosthetic Fit to Cardiovascular Precision Diagnostics

A concrete example is the digital fit optimization of prosthetics. With cost-effective ultrasound technology, combined volume imaging, and AI, the shape and texture of the stump and tissue are precisely captured—forming the basis for custom-made, accurately fitting prosthetic sockets.Further developments target non-invasive blood pressure analytics. While conventional cuffs only measure arterial pressure, new imaging and modeling approaches also address venous return—a key factor in heart failure.

The focus is on the fusion of chip, algorithm, and device design. Smart Medical Devices are meant not only to measure but also to prepare clinically relevant decisions—such as by correlating tissue stiffness and load data in patients with cardiovascular risk factors.

AI-Powered Real-Time Analytics

A central component of the system architecture is integrated real-time analysis through AI. Using synthetic training data and inverse models, tissue and pressure conditions can be simulated and directly interpreted—even on mobile platforms.

During clinical trials, the newly developed algorithms have already been compared with conventional methods. Initial results show accuracy comparable to established methods—offering significantly greater user comfort and potential for home use.

The collaboration between imec and MIT is embedded in the innovative environment of Cambridge, USA, which is considered a global hotspot for biotechnology, IT, and medical technology. The aim is to shorten development times and make market-ready solutions available more quickly.

In the long term, the data collected should not only be used for diagnosis and monitoring but also serve as the foundation for a digital, dynamic health profile. This will make preventive, personalized medicine a reality.